These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1634046)

  • 21. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y; Akbar SM; Horiike N; Joko K; Onji M
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional analysis of immune-related genes in dendritic cells from hepatitis B surface antigen (HBsAg)-positive transgenic mice and regulation of Fc gamma receptor IIB by HBsAg-anti-HBs complex.
    Yao X; Wang XY; Zhao C; Sun SH; Meng ZF; Zhang JM; Xu JQ; Xie YH; Yuan ZH; Wen YM
    J Med Virol; 2011 Jan; 83(1):78-87. PubMed ID: 21108342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation.
    Gupta S; Aragona E; Vemuru RP; Bhargava KK; Burk RD; Chowdhury JR
    Hepatology; 1991 Jul; 14(1):144-9. PubMed ID: 2066062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
    Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
    Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody.
    Davis HL; Michel ML; Whalen RG
    Hum Mol Genet; 1993 Nov; 2(11):1847-51. PubMed ID: 8281146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.
    Lo CM; Fung JT; Lau GK; Liu CL; Cheung ST; Lai CL; Fan ST; Wong J
    Hepatology; 2003 Jan; 37(1):36-43. PubMed ID: 12500186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
    Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A functional model of hepatocyte transplantation for in vivo immunologic studies.
    Bumgardner GL; Heininger M; Li J; Xia D; Parker-Thornburg J; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):53-61. PubMed ID: 9448144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
    Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
    J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure.
    Gupta S; Yerneni PR; Vemuru RP; Lee CD; Yellin EL; Bhargava KK
    Hum Gene Ther; 1993 Jun; 4(3):249-57. PubMed ID: 8338873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
    Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
    J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions.
    Schilling R; Ijaz S; Davidoff M; Lee JY; Locarnini S; Williams R; Naoumov NV
    J Virol; 2003 Aug; 77(16):8882-92. PubMed ID: 12885906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.